Did you know that 3 out of 4 individuals with type 2 diabetes and obesity treated by Roux-en-Y gastric bypass experienced diabetes remission after a year? https://t.co/Iun1gR8gCc https://t.co/UU2QxkI3aI
RT @profbdcohen: More evidence for bariatric surgery as more than weight loss surgery. https://t.co/7u0dCkkIuG via @MedscapeEndo @Medscape…
More evidence for bariatric surgery as more than weight loss surgery. https://t.co/7u0dCkkIuG via @MedscapeEndo @Medscape @TheEndoSociety Madsen, L.R., Baggesen, L.M., Richelsen, B. et al. Diabetologia (2019) 62: 611. https://t.co/at3INZ0WhG #OBSM #BIO370
RT @PSchauerMD: This study and many others support the @AmDiabetesAssn recommendations for metabolic surgery in patients with BMI of 35 or…
RT @PSchauerMD: This study and many others support the @AmDiabetesAssn recommendations for metabolic surgery in patients with BMI of 35 or…
RT @PSchauerMD: This study and many others support the @AmDiabetesAssn recommendations for metabolic surgery in patients with BMI of 35 or…
RT @PSchauerMD: This study and many others support the @AmDiabetesAssn recommendations for metabolic surgery in patients with BMI of 35 or…
RT @AbdTahrani: Great efficacy of RYGB in real life T2 #diabetes . We will show real UK outcomes in the #ECO2019 #EASD2109 and #UKCO2019 .…
RT @AbdTahrani: Great efficacy of RYGB in real life T2 #diabetes . We will show real UK outcomes in the #ECO2019 #EASD2109 and #UKCO2019 .…
RT @NeilFlochMD: 73% did not relapse https://t.co/V4nJxqO0mH
RT @parthaskar: Ah ...what’s the relapse rate of low carb and low calorie diets - any ideas? @lowcarbGP @Dr__Guess https://t.co/OG0c8LZeML
RT @kamleshkhunti: 74% of people with T2 diabetes undergoing Roux-en-Y gastric bypass surgery had remission at 12 months – but 27% relapsed…
RT @kamleshkhunti: 74% of people with T2 diabetes undergoing Roux-en-Y gastric bypass surgery had remission at 12 months – but 27% relapsed…
RT @kamleshkhunti: 74% of people with T2 diabetes undergoing Roux-en-Y gastric bypass surgery had remission at 12 months – but 27% relapsed…
RT @kamleshkhunti: 74% of people with T2 diabetes undergoing Roux-en-Y gastric bypass surgery had remission at 12 months – but 27% relapsed…
RT @kamleshkhunti: 74% of people with T2 diabetes undergoing Roux-en-Y gastric bypass surgery had remission at 12 months – but 27% relapsed…
RT @NeilFlochMD: 73% did not relapse https://t.co/V4nJxqO0mH
Remission definition: A1c <6% with Metformin or <6.5% with no meds
RT @kamleshkhunti: 74% of people with T2 diabetes undergoing Roux-en-Y gastric bypass surgery had remission at 12 months – but 27% relapsed…
RT @kamleshkhunti: 74% of people with T2 diabetes undergoing Roux-en-Y gastric bypass surgery had remission at 12 months – but 27% relapsed…
RT @kamleshkhunti: 74% of people with T2 diabetes undergoing Roux-en-Y gastric bypass surgery had remission at 12 months – but 27% relapsed…
RT @kamleshkhunti: 74% of people with T2 diabetes undergoing Roux-en-Y gastric bypass surgery had remission at 12 months – but 27% relapsed…
RT @kamleshkhunti: 74% of people with T2 diabetes undergoing Roux-en-Y gastric bypass surgery had remission at 12 months – but 27% relapsed…
73% did not relapse
RT @kamleshkhunti: 74% of people with T2 diabetes undergoing Roux-en-Y gastric bypass surgery had remission at 12 months – but 27% relapsed…
RT @kamleshkhunti: 74% of people with T2 diabetes undergoing Roux-en-Y gastric bypass surgery had remission at 12 months – but 27% relapsed…
RT @kamleshkhunti: 74% of people with T2 diabetes undergoing Roux-en-Y gastric bypass surgery had remission at 12 months – but 27% relapsed…
RT @AbdTahrani: Great efficacy of RYGB in real life T2 #diabetes . We will show real UK outcomes in the #ECO2019 #EASD2109 and #UKCO2019 .…
RT @kamleshkhunti: 74% of people with T2 diabetes undergoing Roux-en-Y gastric bypass surgery had remission at 12 months – but 27% relapsed…
Ah ...what’s the relapse rate of low carb and low calorie diets - any ideas? @lowcarbGP @Dr__Guess
RT @kamleshkhunti: 74% of people with T2 diabetes undergoing Roux-en-Y gastric bypass surgery had remission at 12 months – but 27% relapsed…
RT @kamleshkhunti: 74% of people with T2 diabetes undergoing Roux-en-Y gastric bypass surgery had remission at 12 months – but 27% relapsed…
RT @kamleshkhunti: 74% of people with T2 diabetes undergoing Roux-en-Y gastric bypass surgery had remission at 12 months – but 27% relapsed…
RT @kamleshkhunti: 74% of people with T2 diabetes undergoing Roux-en-Y gastric bypass surgery had remission at 12 months – but 27% relapsed…
Great efficacy of RYGB in real life T2 #diabetes . We will show real UK outcomes in the #ECO2019 #EASD2109 and #UKCO2019 . Of note: greate remission than DiRECT and T2 #diabetes remains a progressive disease 😉 @UoB_IAHR @Nirantharakumar @anuradhaa_s #
RT @kamleshkhunti: 74% of people with T2 diabetes undergoing Roux-en-Y gastric bypass surgery had remission at 12 months – but 27% relapsed…
RT @kamleshkhunti: 74% of people with T2 diabetes undergoing Roux-en-Y gastric bypass surgery had remission at 12 months – but 27% relapsed…
74% of people with T2 diabetes undergoing Roux-en-Y gastric bypass surgery had remission at 12 months – but 27% relapsed at 5 years https://t.co/PrJSXMIYjn @youngdiab @ABCDiab @IntDiabetesFed @LDC_tweets @DiabetesUK @ADA_DiabetesPro @AbdTahrani @NeilFloc
According to study, 3 out of 4 individuals with type 2 diabetes and obesity treated by Roux-en-Y gastric bypass experienced diabetes remission as a clear predictor of reduced microvascular complications after 1 year. https://t.co/Iun1gQQFdC https://t.co/
RT @PSchauerMD: This study and many others support the @AmDiabetesAssn recommendations for metabolic surgery in patients with BMI of 35 or…
RT @PSchauerMD: This study and many others support the @AmDiabetesAssn recommendations for metabolic surgery in patients with BMI of 35 or…
RT @caschiavon: “In routine clinical care, three out of four individuals with T2D and obesity treated by RYGB experienced diabetes remissio…
RT @PSchauerMD: This study and many others support the @AmDiabetesAssn recommendations for metabolic surgery in patients with BMI of 35 or…
Effect of Roux-en-Y gastric bypass surgery on diabetes remission and complications in individuals with type 2 diabetes: a Danish population-based matched cohort study. #diebetes #kidneydiseasemonth https://t.co/3EyStgIte4
RT @PSchauerMD: This study and many others support the @AmDiabetesAssn recommendations for metabolic surgery in patients with BMI of 35 or…
RT @PSchauerMD: This study and many others support the @AmDiabetesAssn recommendations for metabolic surgery in patients with BMI of 35 or…
RT @PSchauerMD: This study and many others support the @AmDiabetesAssn recommendations for metabolic surgery in patients with BMI of 35 or…
RT @PSchauerMD: This study and many others support the @AmDiabetesAssn recommendations for metabolic surgery in patients with BMI of 35 or…
RT @PSchauerMD: This study and many others support the @AmDiabetesAssn recommendations for metabolic surgery in patients with BMI of 35 or…
This study and many others support the @AmDiabetesAssn recommendations for metabolic surgery in patients with BMI of 35 or greater and Type 2 diabetes. Patients with BMI 30-35 may benefit as well. Learn what are barriers to surgery @WCITDiabetes @FRubinoMD
RT @caschiavon: “In routine clinical care, three out of four individuals with T2D and obesity treated by RYGB experienced diabetes remissio…
RT @caschiavon: “In routine clinical care, three out of four individuals with T2D and obesity treated by RYGB experienced diabetes remissio…
RT @caschiavon: “In routine clinical care, three out of four individuals with T2D and obesity treated by RYGB experienced diabetes remissio…
RT @caschiavon: “In routine clinical care, three out of four individuals with T2D and obesity treated by RYGB experienced diabetes remissio…
RT @caschiavon: “In routine clinical care, three out of four individuals with T2D and obesity treated by RYGB experienced diabetes remissio…
RT @caschiavon: “In routine clinical care, three out of four individuals with T2D and obesity treated by RYGB experienced diabetes remissio…
“In routine clinical care, three out of four individuals with T2D and obesity treated by RYGB experienced diabetes remission after 1 year, whereas 27% of these had relapsed at 5 years follow-up.”https://t.co/fwgJPaLKLs @WCITDiabetes @PSchauerMD @FRubinoMD
New Danish population-based study by @MadsenRing @dr_rwt and coauthors from @AUHdk @DCEAarhus confirms benefits of Roux-en-Y gastric bypass surgery on type 2 diabetes remission and complications #RealWorldEvidence https://t.co/E8Jws7aLq0 #toptweet https:/
RT @JNJMedDeviceUKI: We recognise that #obesity and #T2D are life-altering conditions, affecting physical and mental health and reducing li…
Effect of Roux-en-Y gastric bypass surgery on diabetes remission and complications in individuals with type 2 diabetes: a Danish population-based matched cohort study https://t.co/NOpQoIeZtz
RT @JLMendezMora: La cirugía de bypass gástrico provoca que la diabetes tipo 2 entre en remisión en la mayoría de pacientes (Diabetologia)…
RT @DiabetologiaJnl: New Danish population-based study by @MadsenRing @dr_rwt and coauthors from @AUHdk @DCEAarhus confirms benefits of Rou…
Goede 5-jaars resultaten tav het wegblijven van diabetes na een #gastricbypass. Maar wat zijn de écht lange termijn resultaten in termen van #diabetes en #vitaminedefficiënties
@aomran229 @F_AlFaleh https://t.co/vthMYpoK5j ولك الشكر الجزيل. https://t.co/Pscap67sFR
RT @DiabetologiaJnl: New Danish population-based study by @MadsenRing @dr_rwt and coauthors from @AUHdk @DCEAarhus confirms benefits of Rou…
New Danish population-based study by @MadsenRing @dr_rwt and coauthors from @AUHdk @DCEAarhus confirms benefits of Roux-en-Y gastric bypass surgery on type 2 diabetes remission and complications #RealWorldEvidence https://t.co/E8Jws6Ta1q https://t.co/wnhJI
La cirugía de bypass gástrico provoca que la diabetes tipo 2 entre en remisión en la mayoría de pacientes (Diabetologia) 12 feb. 2019 Un nuevo estudio publicado en Diabetologia muestra que tres cuartas partes de las... https://t.co/qo96kV72vC
【デンマーク、ルーワイ胃バイパス術施行2型DMと、マッチさせた非手術2型DM 1074例、5.3年比較:手術群で細小血管症リスクは有意に低かった [HR 0.76, 95%CI 0.49-1.18] が、大血管症は0.76 [0.49-1.18]。手術群の2型DM再発率は27%】 Diabetologia https://t.co/fF05t9QHhN
Flot dansk studie, selvom der er DM relaps er det stadig en imponerende remission efter 5 år
RT @DiabetologiaJnl: Gastric bypass surgery remits T2D in most patients. Predictors of success include age HbA1c, insulin use, diabetes dur…
We recognise that #obesity and #T2D are life-altering conditions, affecting physical and mental health and reducing life expectancy. We believe that everyone suffering should receive access to effective treatment and care #EthiconUKI
RT @DiabetologiaJnl: Gastric bypass surgery remits T2D in most patients. Predictors of success include age HbA1c, insulin use, diabetes dur…
RT @DiabetologiaJnl: Gastric bypass surgery remits T2D in most patients. Predictors of success include age HbA1c, insulin use, diabetes dur…
RT @DiabetologiaJnl: Gastric bypass surgery remits T2D in most patients. Predictors of success include age HbA1c, insulin use, diabetes dur…
RT @dr_rwt: Important data for patients and providers. Proud of your work Lene! @MadsenRing ☀️@dceaarhus https://t.co/GwvhJjAvvf
RT @DiabetologiaJnl: Gastric bypass surgery remits T2D in most patients. Predictors of success include age HbA1c, insulin use, diabetes dur…
Diabetologia: Le pontage gastrique évite le DT2 chez la plupart des patients. Les facteurs prédictifs du succès sont l'âge, l'HbA1c, l'utilisation d'insuline, la durée et la gravité du diabète et le sexe. @MadsenRing@dr_rwt@AUHdk@DCEAarhus . #T2D#RYGB#Real
Gastric bypass surgery remits T2D in most patients. Predictors of success include age HbA1c, insulin use, diabetes duration and severity and sex. @MadsenRing @dr_rwt @AUHdk @DCEAarhus. #T2D #RYGB #RealWorldEvidence https://t.co/eNE2QmdTEV
@Clive_G_Brown But the diabetes-remission component of this study is presumably not the interesting point; the Diabetologia paper cites a 2013 paper titled "Gastric Bypass and Sleeve Gastrectomy for Type 2 Diabetes: A Systematic Review and Meta-analysis of
RT @DiabetologiaJnl: New Danish population-based study by @MadsenRing @dr_rwt and coauthors from @AUHdk @DCEAarhus confirms benefits of Rou…
RT @Kaththomasset: More data on the potential benefits of Roux-en-Y gastric bypass surgery in combating #T2D https://t.co/IUreTFV0Tf
More data on the potential benefits of Roux-en-Y gastric bypass surgery in combating #T2D
Important data for patients and providers. Proud of your work Lene! @MadsenRing ☀️@dceaarhus
New Danish population-based study by @MadsenRing @dr_rwt and coauthors from @AUHdk @DCEAarhus confirms benefits of Roux-en-Y gastric bypass surgery on type 2 diabetes remission and complications #RealWorldEvidence https://t.co/eNE2QlWigl @EASDnews https://